price
NASDAQ · ELVN
Enliven Therapeutics, Inc.
Healthcare · Biotechnology
$57.92
Up+$0.14 (+0.24%)
Updated Aug 13, 2026, 9:48 PM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.11B
- P/E ratio
- -9.76
- Dividend yield
- 0.00%
- 52-week range
- $26.70 – $62.32
- Volume
- 1.01M
- Avg. volume
- 581.23K
Price performance
ELVN price history
1M range · 21 trading sessions · Daily adjusted prices
ELVN closed at $57.92 after 21 trading sessions, up 8.95% for the selected period.
- Last close
- $57.92
- Period change
- +8.95%
- Period low
- $50.86
- Period high
- $61.11
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 12, 2026 | $59.09 | $60.3753 | $57.68 | $57.92 | 1.01M |
| Aug 11, 2026 | $59.25 | $59.27 | $57.39 | $58.78 | 1.28M |
| Aug 10, 2026 | $59.89 | $60.99 | $58.52 | $59.42 | 620.96K |
| Aug 7, 2026 | $60.18 | $61.765 | $59.73 | $60.46 | 696.07K |
| Aug 6, 2026 | $59.34 | $61.86 | $59.11 | $60.27 | 1.68M |
| Aug 5, 2026 | $61.01 | $62.32 | $57.47 | $59.70 | 1.72M |
| Aug 4, 2026 | $58.58 | $61.29 | $57.54 | $61.11 | 2.53M |
| Aug 3, 2026 | $54.85 | $59.72 | $52.73 | $58.04 | 2.83M |
| Jul 31, 2026 | $54.10 | $55.815 | $53.10 | $54.81 | 660.43K |
| Jul 30, 2026 | $53.04 | $54.81 | $52.7501 | $53.95 | 648.09K |
| Jul 29, 2026 | $53.99 | $54.50 | $52.20 | $52.97 | 854.01K |
| Jul 28, 2026 | $52.85 | $54.12 | $52.00 | $53.76 | 727.22K |
| Jul 27, 2026 | $53.41 | $55.79 | $52.535 | $52.735 | 1.41M |
| Jul 24, 2026 | $53.15 | $53.71 | $51.74 | $52.95 | 368.77K |
| Jul 23, 2026 | $52.23 | $53.44 | $51.59 | $52.81 | 656.03K |
| Jul 22, 2026 | $54.01 | $54.265 | $52.77 | $52.85 | 448.19K |
| Jul 21, 2026 | $52.23 | $54.88 | $51.965 | $54.33 | 636.62K |
| Jul 20, 2026 | $52.55 | $53.45 | $51.39 | $51.67 | 581.02K |
| Jul 17, 2026 | $49.72 | $54.10 | $49.56 | $53.20 | 818.04K |
| Jul 16, 2026 | $53.08 | $53.8895 | $50.01 | $50.86 | 867.04K |
| Jul 15, 2026 | $51.52 | $53.24 | $50.89 | $53.16 | 500.76K |
Latest ELVN news
The latest Smart Investors Daily articles mentioning ELVN.
Stock researchResearch & News · SEC Filings
Loading stock research…